27 related articles for article (PubMed ID: 9835762)
1. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET in the detection of gastrointestinal metastases in melanoma.
Tatlidil R; Mandelkern M
Melanoma Res; 2001 Jun; 11(3):297-301. PubMed ID: 11468519
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
Wagner JD
Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
[No Abstract] [Full Text] [Related]
4. A role for FDG-PET in the surgical management of stage IV melanoma.
Wagner JD
Ann Surg Oncol; 2004 Aug; 11(8):721-2. PubMed ID: 15249339
[No Abstract] [Full Text] [Related]
5. PET--elegant research tool now elegant clinical tool.
Coleman RE
Semin Roentgenol; 2002 Apr; 37(2):98. PubMed ID: 12134371
[No Abstract] [Full Text] [Related]
6. Current status of clinical PET.
Berridge MS
J Nucl Med; 1994 Jan; 35(1):192. PubMed ID: 8271054
[No Abstract] [Full Text] [Related]
7. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
8. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
9. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Rehani B; Strohmeyer P; Jacobs M; Mantil J
Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma: PET/CT as a staging procedure.
Müller SP
Front Radiat Ther Oncol; 2006; 39():159-170. PubMed ID: 16394679
[No Abstract] [Full Text] [Related]
11. [FDG-PET in the staging of malignant melanoma].
Eigtved A
Nord Med; 1998 Nov; 113(9):301-2. PubMed ID: 9835762
[TBL] [Abstract][Full Text] [Related]
12. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
